129 related articles for article (PubMed ID: 15168660)
1. Role of VLDL receptor in the process of foam cell formation.
Qu S; Wu F; Tian J; Li Y; Wang Y; Wang Y; Zong Y
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(1):1-4, 8. PubMed ID: 15168660
[TBL] [Abstract][Full Text] [Related]
2. Function and significance of very low density lipoprotein receptor subtype II.
Tian J; Bi H; Li Y; Yang P; Zong Y; Wang Y; Qu S
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):229-33. PubMed ID: 16201256
[TBL] [Abstract][Full Text] [Related]
3. Beta-migrating very low density lipoproteins induce foam cell formation in mouse mesangial cells.
Nishikawa T; Kobori S; Takeda H; Higashi T; Sato Y; Sasahara T; Yano T; Kasho M; Anami Y; Shichiri M
Atherosclerosis; 1995 Apr; 114(1):123-32. PubMed ID: 7605371
[TBL] [Abstract][Full Text] [Related]
4. Relative importance of the LDL receptor and scavenger receptor class B in the beta-VLDL-induced uptake and accumulation of cholesteryl esters by peritoneal macrophages.
Herijgers N; Van Eck M; Korporaal SJ; Hoogerbrugge PM; Van Berkel TJ
J Lipid Res; 2000 Jul; 41(7):1163-71. PubMed ID: 10884299
[TBL] [Abstract][Full Text] [Related]
5. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development.
Hiltunen TP; Luoma JS; Nikkari T; Ylä-Herttuala S
Circulation; 1998 Mar; 97(11):1079-86. PubMed ID: 9531255
[TBL] [Abstract][Full Text] [Related]
6. Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages.
Gianturco SH; Bradley WA; Gotto AM; Morrisett JD; Peavy DL
J Clin Invest; 1982 Jul; 70(1):168-78. PubMed ID: 6282937
[TBL] [Abstract][Full Text] [Related]
7. The very low- and intermediate-density lipoprotein fraction isolated from apolipoprotein E-knockout mice transforms macrophages to foam cells through an apolipoprotein E-independent pathway.
Hakamata H; Sakaguchi H; Zhang C; Sakashita N; Suzuki H; Miyazaki A; Takeya M; Takahashi K; Kitamura N; Horiuchi S
Biochemistry; 1998 Sep; 37(39):13720-7. PubMed ID: 9753460
[TBL] [Abstract][Full Text] [Related]
8. Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.
Takahashi S
J Atheroscler Thromb; 2017 Jun; 24(6):552-559. PubMed ID: 28428482
[TBL] [Abstract][Full Text] [Related]
9. Very-low-density lipoprotein-induced triglyceride accumulation in human mesangial cells is mainly mediated by lipoprotein lipase.
Li J; Li H; Wen YB; Li XW
Nephron Physiol; 2008; 110(1):p1-10. PubMed ID: 18698144
[TBL] [Abstract][Full Text] [Related]
10. Characterization of alpha 2-macroglobulin receptor low density lipoprotein receptor-related protein (alpha 2 MR/LRP) in White Carneau pigeon peritoneal macrophages: its role in lipoprotein metabolism.
Seo T; Wang HC; Feldman SR; St Clair RW
Biochim Biophys Acta; 1997 Jan; 1344(2):171-88. PubMed ID: 9030194
[TBL] [Abstract][Full Text] [Related]
11. Foam cells in explants of atherosclerotic rabbit aortas have receptors for beta-very low density lipoproteins and modified low density lipoproteins.
Pitas RE; Innerarity TL; Mahley RW
Arteriosclerosis; 1983; 3(1):2-12. PubMed ID: 6297442
[TBL] [Abstract][Full Text] [Related]
12. Lipid accumulation and foam cell formation in Chinese hamster ovary cells overexpressing very low density lipoprotein receptor.
Suzuki J; Takahashi S; Oida K; Shimada A; Kohno M; Tamai T; Miyabo S; Yamamoto T; Nakai T
Biochem Biophys Res Commun; 1995 Jan; 206(3):835-42. PubMed ID: 7832794
[TBL] [Abstract][Full Text] [Related]
13. Low density lipoprotein receptor of macrophages facilitates atherosclerotic lesion formation in C57Bl/6 mice.
Herijgers N; Van Eck M; Groot PH; Hoogerbrugge PM; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1961-7. PubMed ID: 10938018
[TBL] [Abstract][Full Text] [Related]
14. The LDL receptor is the major pathway for beta-VLDL uptake by mouse peritoneal macrophages.
Perrey S; Ishibashi S; Kitamine T; Osuga J; Yagyu H; Chen Z; Shionoiri F; Iizuka Y; Yahagi N; Tamura Y; Ohashi K; Harada K; Gotoda T; Yamada N
Atherosclerosis; 2001 Jan; 154(1):51-60. PubMed ID: 11137082
[TBL] [Abstract][Full Text] [Related]
15. Triglyceride-rich lipoprotein metabolism in unique VLDL receptor, LDL receptor, and LRP triple-deficient mice.
Espirito Santo SM; Rensen PC; Goudriaan JR; Bensadoun A; Bovenschen N; Voshol PJ; Havekes LM; van Vlijmen BJ
J Lipid Res; 2005 Jun; 46(6):1097-102. PubMed ID: 15772433
[TBL] [Abstract][Full Text] [Related]
16. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
17. Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation.
Rowe AH; Argmann CA; Edwards JY; Sawyez CG; Morand OH; Hegele RA; Huff MW
Circ Res; 2003 Oct; 93(8):717-25. PubMed ID: 14512442
[TBL] [Abstract][Full Text] [Related]
18. A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation.
Linton MF; Babaev VR; Gleaves LA; Fazio S
J Biol Chem; 1999 Jul; 274(27):19204-10. PubMed ID: 10383427
[TBL] [Abstract][Full Text] [Related]
19. LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice.
Tacken PJ; Teusink B; Jong MC; Harats D; Havekes LM; van Dijk KW; Hofker MH
J Lipid Res; 2000 Dec; 41(12):2055-62. PubMed ID: 11108739
[TBL] [Abstract][Full Text] [Related]
20. The actin cytoskeleton is important for the stimulation of cholesterol esterification by atherogenic lipoproteins in macrophages.
Tabas I; Zha X; Beatini N; Myers JN; Maxfield FR
J Biol Chem; 1994 Sep; 269(36):22547-56. PubMed ID: 8077203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
